Cargando…
Risk Factors for Recurrence of Borderline Ovarian Tumours after Conservative Surgery and Impact on Fertility: A Multicentre Study by the Francogyn Group
Introduction: Borderline ovarian tumours (BOT) represent 10–20% of epithelial tumours of the ovary. Although their prognosis is excellent, the recurrence rate can be as high as 30%, and recurrence in the infiltrative form accounts for 3% to 5% of recurrences. Affecting, in one third of cases, women...
Autores principales: | , , , , , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9267171/ https://www.ncbi.nlm.nih.gov/pubmed/35806930 http://dx.doi.org/10.3390/jcm11133645 |
_version_ | 1784743652757602304 |
---|---|
author | Ozenne, Adele De Berti, Marion Body, Gilles Carcopino, Xavier Graesslin, Olivier Kerbage, Yohan Akladios, Cherif Huchon, Cyrille Bricou, Alexandre Mimoun, Camille Raimond, Emilie Ouldamer, Lobna |
author_facet | Ozenne, Adele De Berti, Marion Body, Gilles Carcopino, Xavier Graesslin, Olivier Kerbage, Yohan Akladios, Cherif Huchon, Cyrille Bricou, Alexandre Mimoun, Camille Raimond, Emilie Ouldamer, Lobna |
author_sort | Ozenne, Adele |
collection | PubMed |
description | Introduction: Borderline ovarian tumours (BOT) represent 10–20% of epithelial tumours of the ovary. Although their prognosis is excellent, the recurrence rate can be as high as 30%, and recurrence in the infiltrative form accounts for 3% to 5% of recurrences. Affecting, in one third of cases, women of childbearing age, the surgical strategy with ovarian conservation is now recommended despite a significant risk of recurrence. Few studies have focused exclusively on patients who have received ovarian conservative treatment in an attempt to identify factors predictive of recurrence and the impact on fertility. The objective of this study was to identify the risk factors for recurrence of BOT after conservative treatment and the impact on fertility. Material and methods: This was a retrospective, multicentre study of women who received conservative surgery for BOT between February 1997 and September 2020. We divided the patients into two groups, the “R group” with recurrence and the “NR group” without recurrence. Results: Of 175 patients included, 35 had a recurrence (R group, 20%) and 140 had no recurrence (NR group, 80%). With a mean follow-up of 30 months (IQ 8–62.5), the overall recurrence rate was 20%. Recurrence was BOT in 17.7% (31/175) and invasive in 2.3% (4/175). The mean time to recurrence was 29.5 months (IQ 16.5–52.5). Initial complete peritoneal staging (ICPS) was performed in 42.5% of patients (n = 75). In multivariate analysis, age at diagnosis, nulliparity, advanced FIGO stage, the presence of peritoneal implants, and the presence of a micropapillary component for serous tumours were factors influencing the occurrence of recurrence. The post-surgery fertility rate was 67%. Conclusion: This multicentre study is to date one of the largest studies analysing the risk factors for recurrence of BOT after conservative surgery. Five risk factors were found: age at diagnosis, nulliparity, advanced FIGO stage, the presence of implants, and a micropapillary component. Only 25% of the patients with recurrence underwent ICPS. These results reinforce the interest of initial peritoneal staging to avoid ignoring an advanced tumour stage. |
format | Online Article Text |
id | pubmed-9267171 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2022 |
publisher | MDPI |
record_format | MEDLINE/PubMed |
spelling | pubmed-92671712022-07-09 Risk Factors for Recurrence of Borderline Ovarian Tumours after Conservative Surgery and Impact on Fertility: A Multicentre Study by the Francogyn Group Ozenne, Adele De Berti, Marion Body, Gilles Carcopino, Xavier Graesslin, Olivier Kerbage, Yohan Akladios, Cherif Huchon, Cyrille Bricou, Alexandre Mimoun, Camille Raimond, Emilie Ouldamer, Lobna J Clin Med Article Introduction: Borderline ovarian tumours (BOT) represent 10–20% of epithelial tumours of the ovary. Although their prognosis is excellent, the recurrence rate can be as high as 30%, and recurrence in the infiltrative form accounts for 3% to 5% of recurrences. Affecting, in one third of cases, women of childbearing age, the surgical strategy with ovarian conservation is now recommended despite a significant risk of recurrence. Few studies have focused exclusively on patients who have received ovarian conservative treatment in an attempt to identify factors predictive of recurrence and the impact on fertility. The objective of this study was to identify the risk factors for recurrence of BOT after conservative treatment and the impact on fertility. Material and methods: This was a retrospective, multicentre study of women who received conservative surgery for BOT between February 1997 and September 2020. We divided the patients into two groups, the “R group” with recurrence and the “NR group” without recurrence. Results: Of 175 patients included, 35 had a recurrence (R group, 20%) and 140 had no recurrence (NR group, 80%). With a mean follow-up of 30 months (IQ 8–62.5), the overall recurrence rate was 20%. Recurrence was BOT in 17.7% (31/175) and invasive in 2.3% (4/175). The mean time to recurrence was 29.5 months (IQ 16.5–52.5). Initial complete peritoneal staging (ICPS) was performed in 42.5% of patients (n = 75). In multivariate analysis, age at diagnosis, nulliparity, advanced FIGO stage, the presence of peritoneal implants, and the presence of a micropapillary component for serous tumours were factors influencing the occurrence of recurrence. The post-surgery fertility rate was 67%. Conclusion: This multicentre study is to date one of the largest studies analysing the risk factors for recurrence of BOT after conservative surgery. Five risk factors were found: age at diagnosis, nulliparity, advanced FIGO stage, the presence of implants, and a micropapillary component. Only 25% of the patients with recurrence underwent ICPS. These results reinforce the interest of initial peritoneal staging to avoid ignoring an advanced tumour stage. MDPI 2022-06-23 /pmc/articles/PMC9267171/ /pubmed/35806930 http://dx.doi.org/10.3390/jcm11133645 Text en © 2022 by the authors. https://creativecommons.org/licenses/by/4.0/Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (https://creativecommons.org/licenses/by/4.0/). |
spellingShingle | Article Ozenne, Adele De Berti, Marion Body, Gilles Carcopino, Xavier Graesslin, Olivier Kerbage, Yohan Akladios, Cherif Huchon, Cyrille Bricou, Alexandre Mimoun, Camille Raimond, Emilie Ouldamer, Lobna Risk Factors for Recurrence of Borderline Ovarian Tumours after Conservative Surgery and Impact on Fertility: A Multicentre Study by the Francogyn Group |
title | Risk Factors for Recurrence of Borderline Ovarian Tumours after Conservative Surgery and Impact on Fertility: A Multicentre Study by the Francogyn Group |
title_full | Risk Factors for Recurrence of Borderline Ovarian Tumours after Conservative Surgery and Impact on Fertility: A Multicentre Study by the Francogyn Group |
title_fullStr | Risk Factors for Recurrence of Borderline Ovarian Tumours after Conservative Surgery and Impact on Fertility: A Multicentre Study by the Francogyn Group |
title_full_unstemmed | Risk Factors for Recurrence of Borderline Ovarian Tumours after Conservative Surgery and Impact on Fertility: A Multicentre Study by the Francogyn Group |
title_short | Risk Factors for Recurrence of Borderline Ovarian Tumours after Conservative Surgery and Impact on Fertility: A Multicentre Study by the Francogyn Group |
title_sort | risk factors for recurrence of borderline ovarian tumours after conservative surgery and impact on fertility: a multicentre study by the francogyn group |
topic | Article |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9267171/ https://www.ncbi.nlm.nih.gov/pubmed/35806930 http://dx.doi.org/10.3390/jcm11133645 |
work_keys_str_mv | AT ozenneadele riskfactorsforrecurrenceofborderlineovariantumoursafterconservativesurgeryandimpactonfertilityamulticentrestudybythefrancogyngroup AT debertimarion riskfactorsforrecurrenceofborderlineovariantumoursafterconservativesurgeryandimpactonfertilityamulticentrestudybythefrancogyngroup AT bodygilles riskfactorsforrecurrenceofborderlineovariantumoursafterconservativesurgeryandimpactonfertilityamulticentrestudybythefrancogyngroup AT carcopinoxavier riskfactorsforrecurrenceofborderlineovariantumoursafterconservativesurgeryandimpactonfertilityamulticentrestudybythefrancogyngroup AT graesslinolivier riskfactorsforrecurrenceofborderlineovariantumoursafterconservativesurgeryandimpactonfertilityamulticentrestudybythefrancogyngroup AT kerbageyohan riskfactorsforrecurrenceofborderlineovariantumoursafterconservativesurgeryandimpactonfertilityamulticentrestudybythefrancogyngroup AT akladioscherif riskfactorsforrecurrenceofborderlineovariantumoursafterconservativesurgeryandimpactonfertilityamulticentrestudybythefrancogyngroup AT huchoncyrille riskfactorsforrecurrenceofborderlineovariantumoursafterconservativesurgeryandimpactonfertilityamulticentrestudybythefrancogyngroup AT bricoualexandre riskfactorsforrecurrenceofborderlineovariantumoursafterconservativesurgeryandimpactonfertilityamulticentrestudybythefrancogyngroup AT mimouncamille riskfactorsforrecurrenceofborderlineovariantumoursafterconservativesurgeryandimpactonfertilityamulticentrestudybythefrancogyngroup AT raimondemilie riskfactorsforrecurrenceofborderlineovariantumoursafterconservativesurgeryandimpactonfertilityamulticentrestudybythefrancogyngroup AT ouldamerlobna riskfactorsforrecurrenceofborderlineovariantumoursafterconservativesurgeryandimpactonfertilityamulticentrestudybythefrancogyngroup |